Drug Type Radiopharmaceuticals and diagnostic agent |
Synonyms- |
Action antagonists |
Mechanism endothelin receptor antagonists(Endothelin receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | - | 29 Aug 2024 | |
| Cardiovascular Diseases | Discovery | - | 29 Aug 2024 | |
| Hepatitis | Discovery | - | 29 Aug 2024 | |
| Hypertension, Pulmonary | Discovery | - | 29 Aug 2024 | |
| Kidney Diseases | Discovery | - | 29 Aug 2024 | |
| Neoplasms | Discovery | - | 29 Aug 2024 | |
| Pain | Discovery | - | 29 Aug 2024 |





